Perioperative cardiac evaluation: novel interventions and clinical challenges

Area of Science:

• Cardiology
• Anesthesiology
• Perioperative Medicine

Background:

• Cardiac complications are a major cause of death and illness after noncardiac surgery.
• Estimating preoperative cardiac risk is crucial for patient management.

Purpose of the Study:

• To review the pathophysiology of postoperative cardiac complications.
• To discuss risk indices, guidelines, and pharmacological strategies for risk reduction.

Main Methods:

• Literature review of pathophysiology, risk stratification tools, and evidence for various medications.
• Analysis of recent evidence regarding beta blockers, diltiazem, clonidine, and statins.

Main Results:

• Beta blockers' role is challenged; evidence supports their use mainly in high-risk vascular surgery patients.
• Beta blockers may be ineffective or harmful in low- to intermediate-risk patients and surgeries.
• Diltiazem and clonidine are alternatives for patients with beta blocker contraindications.
• Statins show emerging potential, though evidence is largely retrospective.
• Coronary artery revascularization does not reduce complications in stable coronary artery disease patients.

Conclusions:

• Risk stratification and individualized treatment are essential for managing perioperative cardiac risk.
• The use of beta blockers should be carefully considered based on patient and surgical risk.
• Alternative medications and emerging therapies like statins warrant further investigation.